| Literature DB >> 36014854 |
Jia Shi1, Li He1, Dongmei Yu1, Lahong Ju1, Qiya Guo1, Wei Piao1, Xiaoli Xu1, Liyun Zhao1, Xiaolin Yuan1, Qiuye Cao1, Hongyun Fang1.
Abstract
This descriptive study aimed to determine the prevalence of metabolic syndrome (MetS) and its components among Chinese children and adolescents aged 7-17 from 2016-2017 according to the Cook's criteria modified for age on the basis of the National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III) and to evaluate the associations between the factors of interest (especially vitamin A, vitamin D and hyperuricemia) of MetS and its components, using data from the China National Nutrition and Health Survey of Children and Lactating Mothers from 2016-2017. A total of 54,269 school-aged children and adolescents were ultimately included in this study. Anthropometric measurements and laboratory examinations of the subjects and their relevant information were also collected. A multivariate logistic regression analysis model was applied to analyze the relationships between relevant factors associated with MetS and its components. In the present study, the prevalence of MetS in children and adolescents was 5.98%. Among the five components of MetS, elevated blood pressure (BP) and abdominal obesity were the most prevalent (39.52% and 17.30%), and 58.36% of the subjects had at least one of these components. In the multivariate logistic regression, an overweight condition, obesity and hyperuricemia were positively correlated with the incidence of MetS and all five components. There was also a positive association observed between vitamin A and the risk of MetS and some components of MetS (abdominal obesity and high triglycerides (TG)) and vitamin A was negatively associated with the risk of low high-density lipoprotein cholesterol (HDL-C). Subjects with vitamin D inadequacy had a higher risk of MetS (OR = 1.364, 95%CI: 1.240-1.500) and four of its components, excepting elevated FBG (fast blood glucose). Vitamin D deficiency was positively associated with MetS (OR = 1.646, 95%CI: 1.468-1.845) and all five of its components. Well-designed, large-scale prospective studies are also needed in the future.Entities:
Keywords: China; children and adolescents; epidemiology; metabolic syndrome
Mesh:
Substances:
Year: 2022 PMID: 36014854 PMCID: PMC9415182 DOI: 10.3390/nu14163348
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 6.706
Characteristics of the basic information [n, %].
| Variables | Total ( | Percentage (%) |
|---|---|---|
| Sex | ||
| male | 26,678 | 49.16 |
| female | 27,591 | 50.84 |
| Living area | ||
| urban | 26,561 | 48.94 |
| rural | 27,708 | 51.06 |
| Age group | ||
| prepubertal | 25,558 | 47.10 |
| pubertal | 15,743 | 29.01 |
| post-pubertal | 12,968 | 23.90 |
| Nutritional status | ||
| normal | 42,258 | 77.87 |
| overweight | 6656 | 12.26 |
| obesity | 5355 | 9.87 |
| Hyperuricemia | ||
| no | 38,435 | 70.82 |
| yes | 15,834 | 29.18 |
| Vitamin A | ||
| sufficiency | 45,710 | 84.23 |
| inadequacy | 8071 | 14.87 |
| deficiency | 488 | 0.90 |
| Vitamin D | ||
| sufficiency | 19,142 | 35.27 |
| inadequacy | 24,294 | 44.77 |
| deficiency | 10,833 | 19.96 |
Corresponding indicators of the subjects according to the presence of MetS and its components (median (IQR)).
| Variables | All | With MetS | With Abdominal Obesity | With Elevated FBG | With Elevated BP | With High TG | With |
|---|---|---|---|---|---|---|---|
| Age | 11.77 (9.39, 14.19) | 12.38 (10.23, 15.02) # | 12.06 (9.75, 14.76) $ | 12.57 (10.22, 14.27) ¥ | 11.53 (9.18, 13.98) § | 12.11 (10.09, 14.21) £ | 12.79 (10.36, 15.43) € |
| BMI | 18.19 (16.19, 20.71) | 24.18 (21.27, 27.31) # | 23.44 (21.07, 26.14) $ | 19.07 (16.92, 22.15) ¥ | 18.73 (16.47, 21.77) § | 19.66 (17.15, 23.03) £ | 19.71 (17.26, 23.05) € |
| Anthropometric measurements | |||||||
| Height (cm) | 150 (136, 161) | 156 (146, 166) # | 156 (143, 165) $ | 154 (142, 164) ¥ | 149 (135, 161) § | 152 (141, 161) £ | 155 (142, 166) € |
| Weight (kg) | 41.65 (30.54, 52.64) | 58.40 (46.34, 73.31) # | 56.60 (44.87, 69.30) $ | 46.30 (36.10, 57.72) ¥ | 42.57 (31.00, 54.80) § | 46.28 (35.90, 57.20) £ | 48.92 (36.75, 60.00) € |
| WC (cm) | 63.15 (56.65, 70.45) | 80.00 (72.45, 88.00) # | 79.30 (73.95, 85.60) $ | 65.20 (58.85, 74.00) ¥ | 64.35 (57.10, 72.95) § | 67.15 (59.75, 76.40) £ | 68.00 (60.20, 76.50) € |
| SBP (mmHg) | 111.33 (104.00, 119.67) | 123.17 (117.00, 130.33) # | 118.00 (110.00, 126.00) $ | 116.50 (109.00, 124.00) ¥ | 120.67 (114.67, 126.67) § | 113.67 (105.67, 122.00) £ | 114.00 (105.67, 122.00) € |
| DBP (mmHg) | 66.00 (60.67, 71.67) | 71.67 (66.00, 77.00) # | 68.00 (62.67, 74.00) $ | 68.00 (62.67, 74.33) ¥ | 72.33 (66.67, 77.33) § | 67.00 (61.67, 73.00) £ | 66.33 (61.33, 72.33) € |
| Blood test | |||||||
| FBG (mmol/L) | 5.02 (4.68, 5.34) | 5.07 (4.72, 5.45) # | 5.09 (4.75, 5.41) $ | 6.29 (6.18, 6.54) ¥ | 5.08 (4.74, 5.39) § | 5.04 (4.71, 5.36) £ | 4.89 (4.51, 5, 23) € |
| TG (mmol/L) | 0.81 (0.63, 1.08) | 1.52 (1.28, 1.90) # | 0.98 (0.74, 1.34) $ | 0.90 (0.66, 1.20) ¥ | 0.84 (0.65, 1.13) § | 1.51 (1.35, 1.81) £ | 1.03 (0.76, 1.43) € |
| HDL-C (mmol/L) | 1.38 (1.18, 1.62) | 1.00 (0.90, 1.20) # | 1.26 (1.08, 1.47) $ | 1.41 (1.19, 1.67) ¥ | 1.38 (1.17, 1.62) | 1.22 (1.04, 1.42) £ | 0.94 (0.85, 0.99) € |
| Serum uric acid (µmol/L) | 308.00 (259.00, 369.00) | 358 (297.0, 431.0) # | 344.00 (288.00, 411.00) $ | 349.50 (287.36, 408.00) ¥ | 310.00 (260.00, 373.00) § | 326.00 (274.00, 392.00) £ | 321.00 (261.00, 391.43) € |
| Vitamin A (µg/mL) | 0.40 (0.33, 0.48) | 0.46 (0.38, 0.55) # | 0.43 (0.36, 0.52) $ | 0.40 (0.33, 0.50) ¥ | 0.40 (0.33, 0.49) § | 0.45 (0.38, 0.54) £ | 0.40 (0.33, 0.49) |
| Vitamin D (ng/mL) | 17.3 (12.9, 22.2) | 15.50 (11.90, 20.36) # | 16.4 (12.4, 21.1) $ | 16.55 (12.30, 21.90) ¥ | 16.9 (12.7, 21.9) § | 16.5 (12.3, 21.4) £ | 15, 60 (11.50, 20.37) € |
IQR: interquartile range; MetS: metabolic syndrome; FBG: fast blood glucose; BP: blood pressure; TG: triglyceride; HDL-C: high-density lipoprotein cholesterol; WC: waist circumference; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; # p < 0.05, subjects with MetS vs. without MetS; $ p < 0.05, subjects with abdominal obesity vs. without abdominal obesity; ¥ p < 0.05. subjects with elevated FBG without elevated FBG; § p < 0.05, subjects with elevated BP vs. without elevated BP; £ p < 0.05, subjects with high TG vs. without high TG; € p < 0.05, subjects with low HDL-C vs. without low HDL-C.
Prevalence of MetS and one or more risk factors of MetS [n (%)].
| Variables | Number of Risk Factors | |||
|---|---|---|---|---|
| ≥1 | ≥2 | ≥3 (MetS) | ≥4 | |
| All | 31,671 (58.36) | 11,417 (21.04) | 3244 (5.98) | 648 (1.19) |
| Sex | a | a | a | |
| male | 15,367 (57.60) | 5582 (20.92) | 1681 (6.30) | 374 (1.40) |
| female | 16,304 (59.09) | 5835 (21.15) | 1563 (5.66) | 274 (0.99) |
| Living area | a | a | a | |
| urban | 15,529 (58.47) | 5933 (22.34) | 1771 (6.68) | 369 (1.39) |
| rural | 16,142 (58.26) | 5484 (19.79) | 1471 (5.31) | 279 (1.01) |
| Age group | b | b | b | b |
| prepubertal | 14,641 (57.29) | 4797 (18.77) | 1270 (4.97) | 201 (0.79) |
| pubertal | 9441 (59.97) | 3685 (23.41) | 1080 (6.86) | 238 (1.51) |
| post-pubertal | 7589 (58.52) | 2935 (22.63) | 894 (6.89) | 209 (1.61) |
| Nutritional status | b | b | b | b |
| normal | 21,284 (50.37) | 4832 (11.43) | 685 (1.62) | 45 (0.11) |
| overweight | 5272 (79.21) | 2646 (39.75) | 793 (11.91) | 151 (2.27) |
| obesity | 5115 (95.52) | 3939 (73.56) | 1766 (32.98) | 452 (8.44) |
| Hyperuricemia | a | a | a | a |
| no | 21,578 (56.14) | 6787 (17.66) | 1602 (4.17) | 246 (0.64) |
| yes | 10,093 (63.74) | 4630 (29.24) | 1642 (10.37) | 402 (2.54) |
| Vitamin A | b | b | b | b |
| sufficiency | 27,083 (59.25) | 10,234 (22.39) | 2994 (6.55) | 613 (1.34) |
| inadequacy | 4330 (53.65) | 1117 (13.84) | 241 (2.99) | 35 (0.43) |
| deficiency | 258 (52.87) | 66 (13.52) | 9 (1.84) | 0 (0.00) |
| Vitamin D | b | b | b | b |
| sufficiency | 10,385 (54.25) | 3306 (17.27) | 852 (4.45) | 154 (0.80) |
| inadequacy | 14,451 (59.48) | 5345 (22.00) | 1574 (6.48) | 321 (1.32) |
| deficiency | 6835 (63.09) | 2766 (25.53) | 818 (7.55) | 173 (1.60) |
MetS: metabolic syndrome; a, Chi-square test, p < 0.05; b, Cochran–Armitage trend test, p < 0.05.
Prevalence of the components of MetS in the research population [n (%)].
| Variables | Abdominal Obesity | Elevated FBG | Elevated BP | High TG | Low HDL-C |
|---|---|---|---|---|---|
| All | 9391 (17.30) | 934 (1.72) | 21,446 (39.52) | 8945 (16.48) | 6285 (11.58) |
| Sex | a | a | a | a | |
| male | 4752 (17.81) | 589 (2.21) | 10,529 (39.47) | 3864 (14.48) | 3286 (12.32) |
| female | 4639 (16.81) | 345 (1.25) | 10,917 (39.57) | 5081 (18.42) | 2999 (10.87) |
| Living area | a | a | a | ||
| urban | 5600 (21.08) | 552 (2.08) | 10,117 (38.09) | 4308 (16.22) | 3043 (11.46) |
| rural | 3791 (13.68) | 382 (1.38) | 11,329 (40.89) | 4637 (16.74) | 3242 (11.70) |
| Age group | b | b | b | b | b |
| prepubertal | 4130 (16.16) | 358 (1.40) | 10,602 (41.48) | 3617 (14.15) | 2207 (8.64) |
| pubertal | 2747 (17.45) | 357 (2.27) | 6102 (38.76) | 3122 (19.83) | 2123 (13.49) |
| post-pubertal | 2514 (19.39) | 219 (1.69) | 4742 (36.57) | 2206 (17.01) | 1955 (15.08) |
| Nutritional status | b | b | b | b | b |
| normal | 1791 (4.24) | 634 (1.50) | 14,738 (34.88) | 5572 (13.19) | 4112 (9.73) |
| overweight | 2970 (44.62) | 147 (2.21) | 3291 (49.44) | 1454 (21.84) | 1006 (15.11) |
| obesity | 4630 (86.46) | 153 (2.86) | 3417 (63.81) | 1919 (35.84) | 1167 (21.79) |
| Hyperuricemia | a | a | a | a | a |
| no | 5163 (13.43) | 498 (1.30) | 14,916 (38.81) | 5633 (14.66) | 4010 (10.43) |
| yes | 4228 (26.70) | 436 (2.75) | 6530 (41.24) | 3312 (20.92) | 2275 (14.37) |
| Vitamin A | b | b | b | b | |
| sufficiency | 8495 (18.58) | 787 (1.72) | 18,198 (39.81) | 8278 (18.11) | 5185 (11.34) |
| inadequacy | 854 (10.58) | 134 (1.66) | 3071 (38.05) | 635 (7.87) | 1031 (12.77) |
| deficiency | 42 (8.61) | 13 (2.66) | 177 (36.27) | 32 (6.56) | 69 (14.14) |
| Vitamin D | b | b | b | b | b |
| sufficiency | 2801 (14.63) | 300 (1.57) | 7147 (37.34) | 2793 (14.59) | 1661 (8.68) |
| inadequacy | 4464 (18.37) | 420 (1.73) | 9796 (40.32) | 4111 (16.92) | 2909 (11.97) |
| deficiency | 2126 (19.63) | 214 (1.98) | 4503 (41.57) | 2041 (18.84) | 1715 (15.83) |
FBG: fast blood glucose; BP: blood pressure; TG: triglyceride; HDL-C: high-density lipoprotein cholesterol; a, Chi-square test, p < 0.05; b, Cochran–Armitage trend test, p < 0.05.
Multivariable logistic regression analysis of MetS and its components with related factors.
| Variables | MetS | Abdominal Obesity | Elevated FBG | Elevated BP | High TG | Low HDL-C | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OR (95%CI) |
| OR (95%CI) |
| OR (95%CI) |
| OR (95%CI) |
| OR (95%CI) |
| OR (95%CI) |
| |
| Living area | ||||||||||||
| urban | ref | ref | ref | ref | ref | ref | ||||||
| rural | 1.171 (1.080, 1.268) | 0.0001 | 0.787 (0.738, 0.839) | <0.0001 | 0.694 (0.607, 0.793) | <0.0001 | 1.249 (1.206, 1.295) | <0.0001 | 1.223 (1.167, 1.283) | <0.0001 | 1.106 (1.048, 1.167) | 0.0003 |
| Age group | ||||||||||||
| prepubertal | ref | ref | ref | ref | ref | ref | ||||||
| pubertal | 1.529 (1.384, 1.689) | <0.0001 | 1.519 (1.398, 1.650) | <0.0001 | 1.485 (1.265, 1.743) | <0.0001 | 0.875 (0.837, 0.914) | <0.0001 | 1.329 (1.255, 1.408) | <0.0001 | 1.668 (1.558, 1.786) | <0.0001 |
| post-pubertal | 1.596 (1.433, 1.777) | <0.0001 | 2.048 (1.878, 2.233) | <0.0001 | 1.078 (0.896, 1.298) | 0.4249 | 0.794 (0.756, 0.833) | <0.0001 | 1.055 (0.989, 1.124) | 0.1019 | 1.943 (1.807, 2.088) | <0.0001 |
| Nutritional status | ||||||||||||
| normal | ref | ref | ref | ref | ref | ref | ||||||
| overweight | 8.049 (7.227, 8.966) | <0.0001 | 20.420 (18.997, 21.950) | <0.0001 | 1.277 (1.062, 1.535) | 0.0093 | 1.866 (1.770, 1.967) | <0.0001 | 1.859 (1.740, 1.987) | <0.0001 | 1.654 (1.533, 1.785) | <0.0001 |
| obesity | 31.905 (28.839, 35.296) | <0.0001 | 200.284 (180.901, 221.743) | <0.0001 | 1.554 (1.290, 1.872) | <0.0001 | 3.344 (3.146, 3.554) | <0.0001 | 3.839 (3.593, 4.103) | <0.0001 | 2.826 (2.618, 3.051) | <0.0001 |
| Hyperuricemia | ||||||||||||
| no | ref | ref | ref | ref | ref | ref | ||||||
| yes | 1.560 (1.430, 1.703) | <0.0001 | 1.610 (1.498, 1.731) | <0.0001 | 1.739 (1.501, 2.015) | <0.0001 | 1.049 (1.005, 1.094) | 0.0293 | 1.326 (1.257, 1.400) | <0.0001 | 1.084 (1.018, 1.154) | 0.0117 |
| Vitamin A | ||||||||||||
| sufficiency | ref | ref | ref | ref | ref | ref | ||||||
| inadequacy | 0.647 (0.560, 0.748) | <0.0001 | 0.745 (0.671, 0.827) | <0.0001 | 1.186 (0.980, 1.435) | 0.0803 | 0.931 (0.885, 0.980) | 0.0059 | 0.432 (0.396, 0.471) | <0.0001 | 1.378 (1.279, 1.486) | <0.0001 |
| deficiency | 0.359 (0.180, 0.716) | 0.0036 | 0.413 (0.267, 0.639) | <0.0001 | 1.917 (1.096, 3.356) | 0.0226 | 0.853 (0.705, 1.030) | 0.0988 | 0.357 (0.248, 0.514) | <0.0001 | 1.570 (1.209, 2.038) | 0.0007 |
| Vitamin D | ||||||||||||
| sufficiency | ref | ref | ref | ref | ref | ref | ||||||
| inadequacy | 1.364 (1.240, 1.500) | <0.0001 | 1.270 (1.178, 1.369) | <0.0001 | 1.102 (0.947, 1.283) | 0.2094 | 1.146 (1.100, 1.193) | <0.0001 | 1.120 (1.060, 1.183) | <0.0001 | 1.315 (1.232, 1.404) | <0.0001 |
| deficiency | 1.646 (1.468, 1.845) | <0.0001 | 1.428 (1.302, 1.565) | <0.0001 | 1.283 (1.067, 1.543) | 0.0081 | 1.256 (1.193, 1.322) | <0.0001 | 1.269 (1.186, 1.357) | <0.0001 | 1.712 (1.587, 1.848) | <0.0001 |
The multivariate logistic regression model was adjusted according to sex. MetS: metabolic syndrome, FBG: fast blood glucose; BP: blood pressure; TG: triglyceride; HDL-C: high-density lipoprotein cholesterol, OR: odds ratio, CI: confidence interval.